Shooting Up: A Short History of Drugs and War examines how intoxicants have been put to the service of states, empires and their armies throughout history. Since the beginning of organized combat, armed forces have prescribed drugs to their members for two general purposes: to enhance performance during combat and to counter the trauma of killing and witnessing violence after it is over. Stimulants (e.g. alcohol, cocaine, and amphetamines) have been used to temporarily create better soldiers by that improving stamina, overcoming sleeplessness, eliminating fatigue, and increasing fighting spirit. Downers (e.g. alcohol, opiates, morphine, heroin, marijuana, barbiturates) have also been useful in dealing with the soldier's greatest enemy - shattered nerves. Kamienski's focuses on drugs "prescribed" by military authorities, but also documents the widespread unauthorised consumption by soldiers themselves. Combatants have always treated with various drugs and alcohol, mainly for recreational use and as a reward to themselves for enduring the constant tension of preparing for. Although not officially approved, such "self-medication" is often been quietly tolerated by commanders in so far as it did not affect combat effectiveness. This volume spans the history of combat from the use of opium, coca, and mushrooms in pre-modern warfare to the efforts of modern militaries, during the Cold War in particular, to design psychochemical offensive weapons that can be used to incapacitate rather than to kill the enemy. Along the way, Kamienski provides fascinating coverage of on the European adoption of hashish during Napolean's invasion of Egypt, opium use during the American Civil War, amphetamines in the Third Reich, and the use of narcotics to control child soldiers in the rebel militias of contemporary Africa.

Presenting state-of-the-art, accessible reviews of the expanding science of alcohol treatment, integrated with down to earth, practical guides to the management of a wide range of clinical situations, this new edition is compassionate toward patients, optimistic about treatment, and candid about the clinical and professional challenges embedded in the treatment endeavour. The coverage updates the science that has occurred in the half-decade since the last edition, most notably in the areas of neuroscience, neuroimaging and pharmacotherapy, and includes expanded discussion of historical and public policy forces that have shaped the alcohol treatment field. The book recognizes that drinking problems occur across all social structures and cannot be neatly confined to the specialist addiction treatment sector. This text is relevant to all those working to help those with a drinking problem, meeting the needs of general medical practitioners, psychiatrists and other medical specialists, nurses, psychotherapists, counselors, psychologists, alcohol support workers, social workers and occupational therapists, amongst others.

Recovery Stories is a collection of first-hand accounts by people in recovery from drug and alcohol addiction. Invaluable for those looking to find new, addiction-free ways to live, it contains insights into the lives of real people who hit 'rock bottom' but came back again. Of interest across a wide-range of disciplines, including health, education and social services. Addiction is an illness that kills. Accused of lacking a moral compass and blamed for their own self-destruction, addicts are often forced to live on the margins of society. Afforded little sympathy or support, they may end-up involved in criminality, violence, dishonesty and face despair. They may hit rock bottom when day-to-day survival can become a delicate balance between life and death. But addiction - which occurs in every walk of life - need not be a 'life sentence'. As this book shows, no-one is beyond turning such dire situations around. Recovery Stories is a collection of true stories of triumph over adversity. It tells how the horror of addiction can be overcome, how people can free themselves of their dependency. It is a book of hope and inspiration which will encourage all those seeking 'new ways to live' a full, addiction-free and successful life. 'This book tells the stories that need to be told...Addiction is an illness and has to be seen and tackled as such': Alastair Campbell, Ambassador for Time to Change and Alcohol Concern.

Anger and Rage Addiction & the Self-Pact: New Lights on an Old Nemesis presents a close look at the dynamics of anger and rage, as viewed through the lens of Addiction Theory-drawing on discriminating, diagnostic criteria derived directly from the world of alcoholism and drug addiction. The insights and, more importantly, the ramifications for treatment of Anger and Rage Addiction that result, are profound. They depart decisively from hackneyed, and insufficient, "mitigation, modification and management" strategies that have long been in vogue as the standard approach for treatment of anger and rage "disorders." Moving beyond such rationally based interventions, a new approach, called the Self-Pact, draws completely on the Addiction model to establish its foundation and efficacy. The Self-Pact is presented in detail. The Self-Pact holds considerable promise in both curtailing the mayhem that untreated Anger and Rage Addiction looses on the outer world, and emboldening those afflicted with Anger and Rage Addiction to embark on their own odyssey, replete with discoveries, adventures, reconciliation with self and others, and personal encounters with "whole" states of being.

Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is a cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders. COPE is an integrated treatment, meaning that both the PTSD and substance use disorder are addressed concurrently in therapy by the same clinician, and patients can experience substantial reductions in both PTSD symptoms and substance use severity. Patients use the COPE Patient Workbook while their clinician uses the Therapist Guide to deliver treatment. The program is comprised of 12 individual, 60 to 90 minute therapy sessions. The program includes several components: information about how PTSD symptoms and substance use interact with one another; information about the most common reactions to trauma; techniques to help the patient manage cravings and thoughts about using alcohol or drugs; coping skills to help the patient prevent relapse to substances; a breathing retraining relaxation exercise; and in vivo (real life) and imaginal exposures to target the patient's PTSD symptoms.

Grounded in decades of CBT research and clinical practice, as well as cutting-edge cognitive science, this book provides critical tools for understanding and treating the full range of addictive behaviors. Bruce S. Liese and Aaron T. Beck explain how to systematically develop case conceptualizations and support clients in achieving their recovery goals. The authors use vivid case examples to illustrate CBT techniques, structure, psychoeducation, motivational interviewing, group treatment, relapse prevention, and other effective therapeutic components. Several reproducible forms can be downloaded and printed in a convenient 8 1/2" x 11" size. Reflecting nearly 30 years of important advances in the field, this entirely new book replaces the authors' classic Cognitive Therapy of Substance Abuse.

Have you ever wondered what really happens in rehab

Men in America today may have advantages that women lack. However, in spite of these advantages, men die at a younger age on average than women; men are also more likely than women to have a substance use disorder, to be incarcerated, to be homeless as adults, to die of suicide, and to be victims of violent crime. Conversely, men are less likely than women to seek medical help or behavioural health counselling for any of the problems they face. These significant problems, combined with men's tendency to avoid addressing them, call for a response from behavioural health treatment providers. This book provides an overview of the diverse problems that men with substance use disorders face and serves as both an introduction to the topic and a summary of what is known regarding the subject to date.

Menthol is widely used in consumer and medicinal products and has long been used in cigarettes, often as a flavour-characterising additive. In medical products, menthol is regulated as a drug with restrictions on allowable doses and use. There are no product standards for menthol when used in cigarettes. In this report, The FDA has undertaken a thorough review of the available science concerning menthol cigarettes. To accomplish this task, FDA weighed the collective body of evidence for the impact of the use of menthol in cigarettes on public health. In reviewing the science of menthol smoking, FDA divided the scientific evidence into the following broad categories: smoke chemistry and non-clinical toxicology; physiology; biomarkers; patterns of use; marketing and consumer perception of risk; initiation and progression to regular use; dependence; cessation and disease risk.